First Trust Advisors
SGMO

First Trust Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

First Trust Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-331,982
Closed -$4.16M – 2543
2021
Q1 		$4.16M Buy
331,982
+153,352
+86% +$2.07M 0.01% 1353
2020
Q4 		$2.79M Buy
+178,630
New +$2.09M ﹤0.01% 1408
2019
Q4 		– Sell
-104,771
Closed -$948K – 2450
2019
Q3 		$948K Buy
+104,771
New +$1.18M ﹤0.01% 1895
2019
Q2 		– Sell
-32,254
Closed -$308K – 2493
2019
Q1 		$308K Sell
32,254
-81,407
-72% -$831K ﹤0.01% 2261
2018
Q4 		$1.3M Buy
113,661
+37,344
+49% +$464K ﹤0.01% 1717
2018
Q3 		$1.29M Sell
76,317
-128,233
-63% -$1.95M ﹤0.01% 1861
2018
Q2 		$2.9M Buy
+204,550
New +$3.4M 0.01% 1405

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Trust Advisors's SGMO Position: Q2 2021 in Review

First Trust Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2021, closing a stake of 331,982 shares — an estimated $4.16M sold.

First Trust Advisors first reported a position in SGMO in Q2 2018 and held it in 7 quarters. The position peaked at $4.16M in Q1 2021. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

  • First Trust Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • First Trust Advisors sold 331,982 SANGAMO THERAPEUTICS INC shares in Q2 2021, an estimated $4.16M.
  • First Trust Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2018 and held it in 7 quarters.
  • First Trust Advisors's SANGAMO THERAPEUTICS INC position peaked at $4.16M in Q1 2021.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on First Trust Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.